4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001415889-14-002690
Director sold 30,000 shares at an average $26.88 ($806,400)
- Director acquired 30,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Wells William McDowall Director | 2014-09-02 | Option exercise | +30,000 | $1.36 | $40,800 | 30,000 | D |
| Wells William McDowall Director | 2014-09-02 | Sale | −15,000 | $26.76 | $401,400 | 15,000 | D |
| Wells William McDowall Director | 2014-09-02 | Sale | −15,000 | $27.00 | $405,000 | 0 | D |
| Derivatives | |||||||
| Wells William McDowall Director | 2014-09-02 | Option exercise · Stock Option (right to buy) | −10,000 | 0 | D | ||
| Wells William McDowall Director | 2014-09-02 | Option exercise · Stock option (right to buy) | −20,000 | 24,117 | D | ||
| Open-market sales · 30,000 sh · avg $26.88 · $806,400 | |||||||
Loading xslF345X03/form4-09042014_030951.xml…